Who is the CEO of Galaxy Medicare Ltd?
- Answer Field
-
The company was founded by Mr. Dillip Kumar Das, who has played a key role in shaping its operations.
BAJAJ BROKING
Galaxy Medicare Limited, incorporated in July 1992, is a healthcare-focused company engaged in the manufacturing and export of medical devices, POP bandages, and surgical dressings. The company has steadily expanded its product range to include adhesive tapes, compression bandages, gauze items, wound care solutions, and orthopaedic essentials. Operating through flagship brands such as POP BAND, POP CAST, G CAST, GYPSOSOFT, and CARETAPE, Galaxy Medicare has established a presence in both domestic and international markets. Along with its branded offerings, the company also serves as an OEM partner, delivering customised solutions by sourcing, designing, and manufacturing products as per client specifications.
Its business portfolio further extends to institutional sales through government tenders on the GEM Portal and the export of surgical devices. With 27 registered trademarks and compliance with ISO 9001:2015 and ISO 13485:2016 standards, Galaxy Medicare caters to a wide network of healthcare institutions, including government departments, corporate hospitals, and private medical organisations.
For more details, visit the Galaxy Medicare IPO page.
Details | Information |
IPO Date | September 10, 2025 to September 12, 2025 |
Issue Size | 41,32,000 shares (aggregating up to ₹22.31 Cr) |
Price Band | ₹51 to ₹54 per share |
Lot Size | 2000 shares |
Listing At | SME NSE |
Market Maker | Prabhat Financial Services Ltd. |
Funding Capital Expenditure requirement towards purchase of machinery for the existing manufacturing facility at Bhubaneswar, Odisha.
Funding the working capital requirements
General Corporate Purposes
To meet the offer related expenses
Event | Date |
---|---|
IPO Open Date | Wed, Sep 10, 2025 |
IPO Close Date | Fri, Sep 12, 2025 |
Tentative Allotment | Mon, Sep 15, 2025 |
Initiation of Refunds | Tue, Sep 16, 2025 |
Credit of Shares to Demat | Tue, Sep 16, 2025 |
Tentative Listing Date | Wed, Sep 17, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on Fri, Sep 12, 2025 |
₹51 to ₹54 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,16,000 |
Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,16,000 |
S-HNI (Min) | 3 | 6,000 | ₹3,24,000 |
S-HNI (Max) | 9 | 18,000 | ₹9,72,000 |
B-HNI (Min) | 10 | 20,000 | ₹10,80,000 |
Log in to Your Trading Account: Access your trading account through your broker’s platform.
Navigate to the IPO Section: Go to the IPO section to view active IPO listings.
Select Galaxy Medicare IPO: Find "Galaxy Medicare IPO" and click on the ‘Apply’ button.
Enter Application Details: Specify the number of lots (minimum lot size: 2000 shares) and the bid price within the range of ₹51 to ₹54 per share.
Provide Your UPI ID: Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit: Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on September 12, 2025, to complete your application process.
Additional Read- How to Apply for the Galaxy Medicare IPO?
Total Assets: Grew from ₹32.31 crore in FY23 to ₹31.49 crore as of March 2025.
Total income: Reached ₹40.27 crore in FY25.
Profit After Tax (PAT): Stood at ₹3.37 crore for March 2025.
Net Worth: Recorded at ₹18.36 crore in FY25.
Total Borrowing: Recorded at ₹12.29 crore (March 2025), growing steadily over the years.
EBITDA: Stood at ₹4.58 crore in March 2025.
The company has maintained stability in its asset base, showing consistent operational strength over the recent years.
Its income levels reflect steady business activity, indicating a reliable revenue stream from core operations.
Profitability has remained positive, highlighting the firm’s ability to manage expenses and generate returns.
The net worth position demonstrates financial resilience and an improving equity base.
Borrowings have grown gradually, suggesting the company is leveraging additional funds to support expansion and operational needs.
Operating performance continues to show healthy margins, pointing towards efficiency in cost management and business execution.
The company’s reliance on institutional sales through government tenders may expose it to policy changes, delays in payments, or fluctuations in demand from public sector contracts.
Increasing borrowings to fund operations and expansion could create financial pressure if cash flows do not align with repayment obligations.
Expansion of the product portfolio and investment in new machinery can enhance production capacity and strengthen its presence in both domestic and international markets.
Strong brand recognition, multiple registered trademarks, and compliance with international quality standards create opportunities to capture a wider customer base in healthcare institutions.
KPI | Values |
ROE | 19.88% |
ROCE | 22.38% |
Debt/Equity | 0.25 |
RoNW | 18.35% |
PAT Margin | 8.60% |
EBITDA Margin | 11.69% |
Price to Book Value | 3.49 |
Registrar | Lead Manager(s) |
---|---|
Cameo Corporate Services Ltd. | Affinity Global Capital Market Pvt.Ltd. |
Galaxy Medicare Ltd. Plot No-2, Zone D, Phase A, Mancheswar Industrial Estate Khurda Bhubaneshwar, Odisha, 751010
Phone: +91 9937000991
Email: CS@galaxymed.co.in
Website: http://www.galaxy.in/
Galaxy Medicare IPO presents details of a healthcare-focused company with operations in medical devices, bandages, and surgical dressings. Its business spans branded products, OEM services, institutional sales, and exports, supported by a portfolio of registered trademarks and compliance with quality standards.
The proceeds of the IPO are aimed at funding capital expenditure, working capital requirements, and other corporate purposes. Investors can review the financial track record, operational strengths, and identified risks to understand the company’s position before making decisions.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Galaxy Medicare IPO.
Share this article:
No result found
The company was founded by Mr. Dillip Kumar Das, who has played a key role in shaping its operations.
The IPO will be open for subscription from 10 September 2025 to 12 September 2025.
Galaxy Medicare Limited is engaged in manufacturing and exporting medical devices, POP bandages, surgical dressings, adhesive tapes, compression bandages, wound care solutions, and orthopaedic products. It also undertakes OEM services, institutional sales, and exports. Sustainability of its model depends on demand for medical consumables, its ability to manage costs, and competition in the sector.
The issue comprises 41,32,000 shares, aggregating up to ₹22.31 crore.
Pre-apply allows investors to place a bid for the IPO before the subscription officially opens. Once the IPO opens, these bids are processed automatically.
You will know once you receive a confirmation from your broker or platform after submitting the application and approving the UPI mandate.
The minimum lot size is 2,000 shares. Retail investors need to apply for at least two lots, which equals 4,000 shares.
The tentative allotment date is 15 September 2025.
Cameo Corporate Services Ltd. is the registrar for the IPO.
As per available public disclosures, no governance-related issues or red flags have been reported. Investors should review the company’s filings and prospectus for the latest updates.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading